Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response

Charles J. Ryan, Shreya Shah, Eleni Efstathiou, Matthew R. Smith, Mary Ellen Taplin, Glenn J. Bubley, Christopher J. Logothetis, Thian Kheoh, Christine Kilian, Christopher M. Haqq, Arturo Molina, Eric J. Small

Research output: Contribution to journalArticlepeer-review

203 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response'. Together they form a unique fingerprint.

Medicine & Life Sciences